ARTICLE | Clinical News
Tianeptine: Interim Phase IIa data
February 24, 2014 8:00 AM UTC
Interim data from the first cohort of 8 healthy volunteers receiving infusions of alfentanil in a double-blind, placebo-controlled, crossover, Dutch Phase IIa trial showed that 37.5 mg REV-001 was saf...